Scholar Rock Holding (SRRK) Net Cash Flow (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Net Cash Flow of $106.4 million in Q1 2026, up 189.32% quarter-over-quarter from $36.8 million in Q4 2025, and up 366.19% on a YoY basis from $22.8 million in Q1 2025.

Scholar Rock Holding (SRRK) Net Cash Flow (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Net Cash Flow history runs 10 years deep, the most recent figure standing at $106.4 million for Q1 2026.

  • In Q1 2026, Net Cash Flow rose 366.19% year-over-year to $106.4 million; the TTM figure through Mar 2026 stood at $293.4 million (up 538.46% YoY), while the FY2025 annual figure was $147.1 million, up 93.43% from the prior year.
  • Net Cash Flow was $106.4 million for Q1 2026 at Scholar Rock Holding, up from $36.8 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $205.6 million in Q2 2022 to a low of -$172.7 million in Q3 2022.
  • Historically, Net Cash Flow has averaged $12.8 million across 5 years, with a median of $1.4 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Net Cash Flow tumbled 8912.8% in 2022, then jumped 976.74% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$29.8 million in 2022, then jumped by 214.27% to $34.1 million in 2023, then surged by 198.04% to $101.5 million in 2024, then slumped by 63.78% to $36.8 million in 2025, then jumped by 189.32% to $106.4 million in 2026.
  • The last three Net Cash Flow figures came in at $106.4 million (Q1 2026), $36.8 million (Q4 2025), and $135.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.44 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 625.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -2.44 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 457.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 664,983.53
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 106.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 106.35 Mn
Mar 31, 2026 106.35 Mn
Dec 31, 2025 36.76 Mn
Dec 31, 2025 36.76 Mn
Sep 30, 2025 135.25 Mn
Sep 30, 2025 135.25 Mn
Jun 30, 2025 15.00 Mn
Jun 30, 2025 15.00 Mn
Mar 31, 2025 -39.95 Mn
Mar 31, 2025 -39.95 Mn
Dec 31, 2024 101.49 Mn
Dec 31, 2024 101.49 Mn
Sep 30, 2024 -16.98 Mn
Sep 30, 2024 -16.98 Mn
Jun 30, 2024 1.39 Mn
Jun 30, 2024 1.39 Mn
Mar 31, 2024 -9.88 Mn
Mar 31, 2024 -9.88 Mn
Dec 31, 2023 34.05 Mn
Dec 31, 2023 34.05 Mn